Evaluating the Impact of Defeasible Argumentation as a Modelling Technique for Reasoning under Uncertainty

Limited work exists for the comparison across distinct knowledge-based approaches in Artificial Intelligence (AI) for non-monotonic reasoning, and in particular for the examination of their inferential and explanatory capacity. Non-monotonicity, or defeasibility, allows the retraction of a conclusion in the light of new information. It is a similar pattern to human reasoning, which draws conclusions in the absence of information, but allows them to be corrected once new pieces of evidence arise. Thus, this thesis focuses on a comparison of three approaches in AI for implementation of non-monotonic reasoning models of inference, namely: expert systems, fuzzy reasoning and defeasible argumentation. Three applications from the fields of decision-making in healthcare and knowledge representation and reasoning were selected from real-world contexts for evaluation: human mental workload modelling, computational trust modelling, and mortality occurrence modelling with biomarkers. The link between these applications comes from their presumptively non-monotonic nature. They present incomplete, ambiguous and retractable pieces of evidence. Hence, reasoning applied to them is likely suitable for being modelled by non-monotonic reasoning systems. An experiment was performed by exploiting six deductive knowledge bases produced with the aid of domain experts. These were coded into models built upon the selected reasoning approaches and were subsequently elicited with real-world data. The numerical inferences produced by these models were analysed according to common metrics of evaluation for each field of application. For the examination of explanatory capacity, properties such as understandability, extensibility, and post-hoc interpretability were meticulously described and qualitatively compared. Findings suggest that the variance of the inferences produced by expert systems and fuzzy reasoning models was higher, highlighting poor stability. In contrast, the variance of argument-based models was lower, showing a superior stability of its inferences across different system configurations. In addition, when compared in a context with large amounts of conflicting information, defeasible argumentation exhibited a stronger potential for conflict resolution, while presenting robust inferences. An in-depth discussion of the explanatory capacity showed how defeasible argumentation can lead to the construction of non-monotonic models with appealing properties of explainability, compared to those built with expert systems and fuzzy reasoning. The originality of this research lies in the quantification of the impact of defeasible argumentation. It illustrates the construction of an extensive number of non-monotonic reasoning models through a modular design. In addition, it exemplifies how these models can be exploited for performing non-monotonic reasoning and producing quantitative inferences in real-world applications. It contributes to the field of non-monotonic reasoning by situating defeasible argumentation among similar approaches through a novel empirical comparison

A deep phenotyping approach to understand major depressive disorder and responses to antidepressant pharmacotherapy

Major depressive disorder (MDD) is a debilitating psychiatric disorder characterised by a complex underlying biology and poor response to pharmacological antidepressant strategies. Given the heterogeneity of MDD and the diverse range of available treatment options, there is an increasing desire to develop and implement precision medicine approaches to tailor existing treatment strategies to the biological system of the individual. In this thesis, high-resolution omics data (connectomics [fMRI], metabolomics [1H NMR] and immunomics [inflammatory cytokines]) collected from the Canadian Biomarker Integration Network in Depression (CAN-BIND) study has been integrated to facilitate the deep phenotyping of MDD. In addition, this approach has been used to predict the treatment response to two common antidepressant drugs, monotherapy with the selective serotonin reuptake inhibitor (SSRI) escitalopram (10-20 mg) or combination therapy with escitalopram and the dopaminergic antipsychotic aripiprazole (2-10 mg). This approach identified a multi-modal panel of sex-specific biomarkers of MDD and treatment response, highlighting a strong immunometabolic component in depressed males, but not females. Unsupervised clustering methods indicated the superiority of biological (neuroimaging) over symptom-based (clinical questionnaires) data for the stratification of patients into MDD subtypes with differential response to treatment. More importantly, a set of multi-modal, sex-specific biomarkers were identified that predicted treatment response with escitalopram monotherapy (84.7% accuracy) or aripiprazole augmentation (88.5% accuracy). In addition to highlighting potential new aspects of the biology of MDD (e.g. relevance of lipoprotein size and density for their relation to depression), this work is one of the first attempts to apply systems biology approaches to high-resolution biological data from a large clinical trial to predict later treatment outcome. With the validation of the findings presented in this thesis in independent cohorts, and with further development of omics technologies, leading to cheaper and high-throughput screening of the patient population, pre-dose biomarkers have the potential to achieve personalised treatment. Each year, escitalopram and aripiprazole are prescribed to an estimated 26 million and 7 million individuals respectively, and over one third of them do not respond. Thus, being able to predict response to antidepressant medication from baseline biomarkers has enormous clinical and socioeconomic benefits.Open Acces

Computational Methods for the Analysis of Genomic Data and Biological Processes

In recent decades, new technologies have made remarkable progress in helping to understand biological systems. Rapid advances in genomic profiling techniques such as microarrays or high-performance sequencing have brought new opportunities and challenges in the fields of computational biology and bioinformatics. Such genetic sequencing techniques allow large amounts of data to be produced, whose analysis and cross-integration could provide a complete view of organisms. As a result, it is necessary to develop new techniques and algorithms that carry out an analysis of these data with reliability and efficiency. This Special Issue collected the latest advances in the field of computational methods for the analysis of gene expression data, and, in particular, the modeling of biological processes. Here we present eleven works selected to be published in this Special Issue due to their interest, quality, and originality

Bioinformatic analysis and deep learning on large-scale human transcriptomic data: studies on aging, Alzheimer’s neurodegeneration and cancer

[ES] El objetivo general del proyecto ha sido el análisis bioinformático integrativo de datos múltiples de proteómica y genómica combinados con datos clínicos asociados para la búsqueda de biomarcadores y módulos poligénicos causales aplicado a enfermedades complejas; principalmente, cáncer de origen primario desconocido, en sus distintos tipos y subtipos y enfermedades neurodegenerativas (ND) mayormente Alzheimer, además de neurodegeneración debida a la edad. Además, se ha hecho un uso intensivo de técnicas de inteligencia artificial, más en concreto de técnicas de redes neuronales de aprendizaje profundo para el análisis y pronóstico de dichas enfermedades

Balancing macrophage activation in health and disease:The epigenetic, transcriptional and immunometabolic insights

Macrophages are crucial components of the innate immune system. Macrophages manifest extreme heterogeneity in response to the local milieu. The plasticity and diversity of macrophages are pivotal for host defense against pathogenic insults and the maintenance of tissue homeostasis. However, dysregulated macrophage activation can lead to acute and chronic inflammatory disorders, such as COVID-19, atherosclerosis, and inflammatory bowel diseases. The activation states of macrophages are shaped by various mechanisms, such as epigenetic modifications, transcriptional regulation, and metabolic alterations. This dissertation provides comprehensive transcriptomic and metabolomic profiles of widely used macrophage models. We build a macrophage activation classifier and identify key regulatory network modules constructed by unbiased approaches. Furthermore, our data delivers insights into targeting metabolic pathways, kinases, and epigenetic enzymes for therapeutic development against various diseases. These findings advance our knowledge in macrophage activation and pathogenesis of different diseases and disorders that can support future studies from basic science to translational medicine and from bench to bedside

Public Health

Public health can be thought of as a series of complex systems. Many things that individual living in high income countries take for granted like the control of infectious disease, clean, potable water, low infant mortality rates require a high functioning systems comprised of numerous actors, locations and interactions to work. Many people only notice public health when that system fails. This book explores several systems in public health including aspects of the food system, health care system and emerging issues including waste minimization in nanosilver. Several chapters address global health concerns including non-communicable disease prevention, poverty and health-longevity medicine. The book also presents several novel methodologies for better modeling and assessment of essential public health issues

Genetic algorithm-neural network: feature extraction for bioinformatics data.

With the advance of gene expression data in the bioinformatics field, the questions which frequently arise, for both computer and medical scientists, are which genes are significantly involved in discriminating cancer classes and which genes are significant with respect to a specific cancer pathology. Numerous computational analysis models have been developed to identify informative genes from the microarray data, however, the integrity of the reported genes is still uncertain. This is mainly due to the misconception of the objectives of microarray study. Furthermore, the application of various preprocessing techniques in the microarray data has jeopardised the quality of the microarray data. As a result, the integrity of the findings has been compromised by the improper use of techniques and the ill-conceived objectives of the study. This research proposes an innovative hybridised model based on genetic algorithms (GAs) and artificial neural networks (ANNs), to extract the highly differentially expressed genes for a specific cancer pathology. The proposed method can efficiently extract the informative genes from the original data set and this has reduced the gene variability errors incurred by the preprocessing techniques. The novelty of the research comes from two perspectives. Firstly, the research emphasises on extracting informative features from a high dimensional and highly complex data set, rather than to improve classification results. Secondly, the use of ANN to compute the fitness function of GA which is rare in the context of feature extraction. Two benchmark microarray data have been taken to research the prominent genes expressed in the tumour development and the results show that the genes respond to different stages of tumourigenesis (i.e. different fitness precision levels) which may be useful for early malignancy detection. The extraction ability of the proposed model is validated based on the expected results in the synthetic data sets. In addition, two bioassay data have been used to examine the efficiency of the proposed model to extract significant features from the large, imbalanced and multiple data representation bioassay data

Advanced Image Acquisition, Processing Techniques and Applications

"Advanced Image Acquisition, Processing Techniques and Applications" is the first book of a series that provides image processing principles and practical software implementation on a broad range of applications. The book integrates material from leading researchers on Applied Digital Image Acquisition and Processing. An important feature of the book is its emphasis on software tools and scientific computing in order to enhance results and arrive at problem solution

Pharmacovigilance Decision Support : The value of Disproportionality Analysis Signal Detection Methods, the development and testing of Covariability Techniques, and the importance of Ontology

The cost of adverse drug reactions to society in the form of deaths, chronic illness, foetal malformation, and many other effects is quite significant. For example, in the United States of America, adverse reactions to prescribed drugs is around the fourth leading cause of death. The reporting of adverse drug reactions is spontaneous and voluntary in Australia. Many methods that have been used for the analysis of adverse drug reaction data, mostly using a statistical approach as a basis for clinical analysis in drug safety surveillance decision support. This thesis examines new approaches that may be used in the analysis of drug safety data. These methods differ significantly from the statistical methods in that they utilize co variability methods of association to define drug-reaction relationships. Co variability algorithms were developed in collaboration with Musa Mammadov to discover drugs associated with adverse reactions and possible drug-drug interactions. This method uses the system organ class (SOC) classification in the Australian Adverse Drug Reaction Advisory Committee (ADRAC) data to stratify reactions. The text categorization algorithm BoosTexter was found to work with the same drug safety data and its performance and modus operandi was compared to our algorithms. These alternative methods were compared to a standard disproportionality analysis methods for signal detection in drug safety data including the Bayesean mulit-item gamma Poisson shrinker (MGPS), which was found to have a problem with similar reaction terms in a report and innocent by-stander drugs. A classification of drug terms was made using the anatomical-therapeutic-chemical classification (ATC) codes. This reduced the number of drug variables from 5081 drug terms to 14 main drug classes. The ATC classification is structured into a hierarchy of five levels. Exploitation of the ATC hierarchy allows the drug safety data to be stratified in such a way as to make them accessible to powerful existing tools. A data mining method that uses association rules, which groups them on the basis of content, was used as a basis for applying the ATC and SOC ontologies to ADRAC data. This allows different views of these associations (even very rare ones). A signal detection method was developed using these association rules, which also incorporates critical reaction terms.Doctor of Philosoph

Epilepsy

With the vision of including authors from different parts of the world, different educational backgrounds, and offering open-access to their published work, InTech proudly presents the latest edited book in epilepsy research, Epilepsy: Histological, electroencephalographic, and psychological aspects. Here are twelve interesting and inspiring chapters dealing with basic molecular and cellular mechanisms underlying epileptic seizures, electroencephalographic findings, and neuropsychological, psychological, and psychiatric aspects of epileptic seizures, but non-epileptic as well